Alaunos Therapeutics, Inc. Share Price & Technical Analysis
TCRT · $2.42 (+2.11%)
Healthcare / Biotechnology
$2.42
+2.11%
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. It also develops hunTR TCR discovery platform to target driver mutations. Alaunos The…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-8% return in May, -8% avg return in past 3 year May month.
-31% return in 2026, -43% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -21% | 19% | -6% | -14% | -8% | – | – | – | – | – | – | – | -31% |
| 25 | -11% | -12% | 0% | 79% | 4% | 85% | -44% | -25% | 14% | 13% | 22% | -3% | 122% |
| 24 | 113% | -10% | -13% | -30% | -16% | -38% | -44% | -30% | 23% | -37% | 30% | -32% | -85% |
| 23 | 9% | -24% | 13% | -8% | -12% | 0% | -17% | -68% | -7% | -38% | -12% | 0% | -167% |
| 22 | -1% | -5% | -32% | -18% | -7% | 121% | -6% | 112% | -29% | -34% | -45% | 3% | 60% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. It also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.29M
P/E ratio
—
52W high
$6.20
52W low
$1.67
Volume
15,106
Beta
-1.13
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Alaunos Therapeutics, Inc. share price today?
- Alaunos Therapeutics, Inc. (TCRT) last traded around $2.42 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TCRT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TCRT. Download the app for real-time alerts.
- How can I analyze Alaunos Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.